Laboratory for biochemistry
We investigate glycophenotype changes as the causes and/or consequences of certain physiological and pathophysiological conditions as well as their responses.
Laboratory for biochemistry
Laboratorij za biokemiju
Head of research group
Prof Vedrana Čikeš Čulić
Research
Glycoantigens are the secondary gene products, that means their expression depends upon expression of specific glycosyltransferases and glycosidase which catalyse their synthesis and degradation, respectively. We investigate glycophenotype changes as the causes and/or consequences of certain physiological and pathophysiological conditions as well as their responses to drug therapies.
Active projects
RNazaH2A kao nova meta u dijagnostici i liječenju tumora mokraćnog mjehura
Lead researcher: Assist. Prof Vedrana Čikeš Čulić
Funded by Croatian Agency for SMEs, Innovations and Investments (HAMAG-BICRO)
Duration: jun 2016 - jun 2017
Funded by Croatian Agency for SMEs, Innovations and Investments (HAMAG-BICRO)
Duration: jun 2016 - jun 2017
Markoić - Izražaj glikosfingolipida u regeneriranoj štakorskoj jetri (Ministry of Science and Education)
A. Markotić - Optimiranje čimbenika koji utječu na regeneraciju jetre
Prof Anita Markotić, PhD [CV]
Nikolina Režić Mužinić, PhD [CV]
Teaching Assist Angela Mastelić, PhD [CV]
Sandra Marijan, PhD, professional associate [CV]
Nikolina Režić Mužinić, PhD [CV]
Teaching Assist Angela Mastelić, PhD [CV]
Sandra Marijan, PhD, professional associate [CV]
Future directions
Extension of cooperation in the frame of project „ Biological effects of wine: the influence of vinification technology, dealcoholization and aging of wine“ (No. 8652, PI Mladen Boban) supported by the Croatian Science Foundation. Our current results support critical monocyte subpopulation roles in modulation of the inflammatory microenvironment favourable for cardiomyocyte replenishment after myocardial infarction.
Selected publications and doctoral theses
Interests and topics: glycoantigens; glycosphingolipids; gangliosides; high performance thin layer chromatography, HPTLC; HPTLC binding assay using choleragenoid; flow cytometry; cancer stem cells; myocardial infarction.